BETH M. JANTZEN

Corporate Board Profile

Tech Score: 0/100

← Back to All Directors

APPLIED DNA SCIENCES INC

Filing Date Source Excerpt
2019-10-08 Ms. Beth Jantzen
2024-03-14 Beth M. Jantzen Common Stock 189,185(9)(12)(13)
2024-06-21 If you grant a proxy, the persons named as proxy holders, Ms. Beth Jantzen and Ms. Judith Murrah, will have the discretion to vote your shares on any additional matters properly presented for a vote at the meeting.
2024-12-10 Ms. Beth Jantzen and Ms. Judith Murrah, will have the discretion to vote your shares on any additional matters properly presented for a vote at the meeting.

Data sourced from SEC filings. Last updated: 2025-08-30